comparemela.com

Stephen Barnhill Jr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Hemp : GHG Announces Closing of Debt Settlement -Today at 01:41 am

2023 News Releases Aug 18, 2023 GHG Announces Closing of Debt Settlement Aug 11, 2023 GHG Announces Debt Settlement .

British columbiaUnited statesStephen barnhill jrRd divisionCanadian securities exchangeGlobal hemp group incInformation contact global hemp groupCommon shareStephen barnhillCommon sharesMultilateral instrumentMinority security holdersSpecial transactionsUnited states securities actSecurities actHemp group

Global Hemp Group Inc : Global Hemp Group Concludes First U S Sublicense Related to Its Recently Acquired Exclusive North American License of Apollon Formularies IP

Vancouver, British Columbia (Newsfile Corp. - April 28, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that the Company has executed

United kingdomUnited statesBritish columbiaStephen barnhill jrScott markowitzInformation contact global hemp groupSublicense to medicinal oneBritish columbia newsfile corpZion market researchGlobal hemp group incRd divisionNorth americanApollon formulariesHemp groupNon exclusive sublicenseMedicinal one

Global Hemp Group Inc : Global Hemp Group Announces Jeff Nagel as Product Manufacturing Advisor

Vancouver, British Columbia (Newsfile Corp. - March 30, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that Jeff Nagel has joined

British columbiaUnited kingdomJeff nagelStephen barnhill jrRd divisionProduct development at apollon formulariesBritish columbia newsfile corpCompany advisory boardGlobal hemp group incInformation contact global hemp groupAdvisory boardProduct manufacturingGlobal hemp groupIntellectual propertyApollon formulariesMedical product development

Investegate |Apollon Formularies Announcements | Apollon Formularies: CEO Review of 2021

Investegate announcements from Apollon Formularies, CEO Review of 2021

United statesUniversity of the west indiesSaint andrewUnited kingdomUniversity of texasCity ofStephend barnhillHerb fritscheAnthony hallArchibald mcdonaldAl dawesMarjorie vassellMegan rayStephen barnhill jrTim blytheStene jacobs

Apollon Formularies Plc: Apollon Formularies- CEO Review of 2021

LONDON, Jan. 25, 2022 /PRNewswire/ Apollon Formularies plc (AQSE: APOL) , ("Apollon" or the "Company"), a UK based international pharmaceutical company specializing in medical cannabis and

United statesUniversity of the west indiesSaint andrewUnited kingdomUniversity of texasCity ofStephend barnhillHerb fritscheAnthony hallArchibald mcdonaldAl dawesMarjorie vassellStephen barnhill jrStene jacobsJodi anne mckenley kingDingle spence

vimarsana © 2020. All Rights Reserved.